RU2013127665A - Раствор для первичного заполнения аппарата искусственного кровообращения - Google Patents

Раствор для первичного заполнения аппарата искусственного кровообращения Download PDF

Info

Publication number
RU2013127665A
RU2013127665A RU2013127665/15A RU2013127665A RU2013127665A RU 2013127665 A RU2013127665 A RU 2013127665A RU 2013127665/15 A RU2013127665/15 A RU 2013127665/15A RU 2013127665 A RU2013127665 A RU 2013127665A RU 2013127665 A RU2013127665 A RU 2013127665A
Authority
RU
Russia
Prior art keywords
dextran
solution
cardiopulmonary bypass
oncotic
neoncotic
Prior art date
Application number
RU2013127665/15A
Other languages
English (en)
Russian (ru)
Inventor
Стиг СТЕЕН
Original Assignee
Эксвиво Перфьюжн Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эксвиво Перфьюжн Аб filed Critical Эксвиво Перфьюжн Аб
Publication of RU2013127665A publication Critical patent/RU2013127665A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/721Dextrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
RU2013127665/15A 2010-11-30 2011-11-07 Раствор для первичного заполнения аппарата искусственного кровообращения RU2013127665A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1020300.8A GB201020300D0 (en) 2010-11-30 2010-11-30 Product
GB1020300.8 2010-11-30
PCT/EP2011/069524 WO2012072374A1 (en) 2010-11-30 2011-11-07 Priming solutions for cardiopulmonary bypass

Publications (1)

Publication Number Publication Date
RU2013127665A true RU2013127665A (ru) 2015-01-10

Family

ID=43500877

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013127665/15A RU2013127665A (ru) 2010-11-30 2011-11-07 Раствор для первичного заполнения аппарата искусственного кровообращения

Country Status (10)

Country Link
US (1) US8969323B2 (https=)
EP (1) EP2646040B1 (https=)
JP (1) JP6051164B2 (https=)
CN (1) CN103228285B (https=)
DK (1) DK2646040T3 (https=)
ES (1) ES2575206T3 (https=)
GB (1) GB201020300D0 (https=)
PL (1) PL2646040T3 (https=)
RU (1) RU2013127665A (https=)
WO (1) WO2012072374A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3047360C (en) 2017-01-17 2023-09-26 Xvivo Perfusion Ab Organ preservation and/or perfusion solutions
US11707600B2 (en) * 2020-11-18 2023-07-25 CardioDriven, Inc. Level set calibration and assurance for pulmonary artery pressure catheterization
CN117481629B (zh) * 2023-12-29 2024-03-26 成都水木医疗科技有限公司 一种多功能胶体渗透压仪及其测定方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1594697A (en) 1977-04-19 1981-08-05 Pharmacia Ab Oligosaccharide compositions for parenteral use
SE8900586L (sv) 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US5702880A (en) 1993-06-04 1997-12-30 Biotime, Inc. Blood substitute comprising 0-5 mM K+
SE505499C2 (sv) * 1995-12-15 1997-09-08 Stiftelsen Facthor Förvaringslösning för organ och vävnad eller delar därav från människor och djur innehållande kalcium och nitroglycerin, användning därav samt förfarande för förvaring därmed
US6794124B2 (en) * 1995-12-15 2004-09-21 Stiftelsen Facthor Preservation solution
US5902800A (en) * 1998-03-27 1999-05-11 Glenpharma Dextran formulations and method for treatment of inflammatory joint disorders

Also Published As

Publication number Publication date
DK2646040T3 (en) 2016-06-13
ES2575206T3 (es) 2016-06-27
PL2646040T3 (pl) 2017-04-28
JP2013544265A (ja) 2013-12-12
EP2646040A1 (en) 2013-10-09
CN103228285B (zh) 2016-06-01
US8969323B2 (en) 2015-03-03
CN103228285A (zh) 2013-07-31
JP6051164B2 (ja) 2016-12-27
US20130316977A1 (en) 2013-11-28
GB201020300D0 (en) 2011-01-12
WO2012072374A1 (en) 2012-06-07
EP2646040B1 (en) 2016-03-23

Similar Documents

Publication Publication Date Title
EA201492106A1 (ru) Способ и устройство для контроля экстракорпоральной обработки крови пациента
RU2013129785A (ru) Интерполимерный сшитый гель и способ использования
BR112013026319A2 (pt) método e aparelho para o monitoramento de um tratamento de um paciente, preferivelmente para o monitoramento da hemodiálise, hemodiafiltração e/ou diálise peritoneal
CN102168370A (zh) 一种抗菌织物及其制备方法
EA201201284A1 (ru) Система для обработки крови
GB2568174A8 (en) System and method to efficiently clean a blood filter
JP2009178558A5 (https=)
RU2013127665A (ru) Раствор для первичного заполнения аппарата искусственного кровообращения
RU2013104298A (ru) Применение воды с пониженным содержанием дейтерия для лечения устойчивости к инсулину
Loree et al. In vitro study of a medical device to enhance arteriovenous fistula eligibility and maturation
RU2012128416A (ru) Способ лечения варикозной болезни нижних конечностей с использованием эндовазальной лазерной коагуляции вен
CY1124001T1 (el) Υγρο αιμοκαθαρσης απαλλαγμενο απο ασβεστιο
JP2013544265A5 (https=)
Tylicki et al. Ozone therapy seems to be safe, but is it really clinically effective?
UA96498U (uk) Спосіб кровозбереження при анестезіологічному забезпеченні хірургічної корекції вроджених вад серця у новонароджених в умовах штучного кровообігу
RU2011120563A (ru) Способ лечения язвенных кератитов
RU2007102405A (ru) Способ лечения увеитов
Malchesky Artificial organs 2017: a year in review
RU2010123175A (ru) Способ атравматичного хирургического лечения лапаростомных ран
RU2008127295A (ru) Сорбент для удаления иммуноглобулинов
CN104116671A (zh) 一种丰胸精油
YUAN Influence of hydrochlorothiazide combined valsartan on therapeutic effects, cardiac function and levels of serum RBP4, Vaspin in hypertension patients
Albes Coagulation management in cardiac surgery: Current strategies
Dykukha et al. Correction of complicated coarctation of aorta with partial extracorporal bypass
ZHOU et al. Effect of artificial colloid priming during cardiopulmonary bypass on the coagulation function of pediatric patients weighting less than 5 kg with congenital heart disease

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20141110